The aim of this work is focused on the engineering of biocompatible complex systems composed by an inorganic and bio part. Graphene oxide (GO) and/or graphite oxide (GtO) were taken into account as potential substrate to linkage the protein such as Anemonia sulcata recombinant Green Fluorescent Protein (rAsGFP). The complex system is obtained through a reducing process between GO/GtO and rAsGFP archiving an environmentally friendly biosynthesis. Spectroscopic measurements supports the formation of reduced species. In particular, photoluminescence shows a change in the activity of protein when a bond is formed, highlighted by a loss of the maximum emission signal of rAsGFP and a red-shift of the maximun absorption peak of GO/GtO species. Moreover, the hemolysis assay reveals a lower values in the presence of less oxided graphene species providing evidence for a biocompatible material. This singular aspect can be approached as a promising method for circulating pharmaceutical preparations via intravenous administration in the field of drug delivery.
Low Cost Synthesis of Smart Biocompatible Graphene Oxide Reduced Species by means of GFP
Tiziana Masullo;Paolo Colombo;Salvatore Mazzola;Angela Cuttitta
2015
Abstract
The aim of this work is focused on the engineering of biocompatible complex systems composed by an inorganic and bio part. Graphene oxide (GO) and/or graphite oxide (GtO) were taken into account as potential substrate to linkage the protein such as Anemonia sulcata recombinant Green Fluorescent Protein (rAsGFP). The complex system is obtained through a reducing process between GO/GtO and rAsGFP archiving an environmentally friendly biosynthesis. Spectroscopic measurements supports the formation of reduced species. In particular, photoluminescence shows a change in the activity of protein when a bond is formed, highlighted by a loss of the maximum emission signal of rAsGFP and a red-shift of the maximun absorption peak of GO/GtO species. Moreover, the hemolysis assay reveals a lower values in the presence of less oxided graphene species providing evidence for a biocompatible material. This singular aspect can be approached as a promising method for circulating pharmaceutical preparations via intravenous administration in the field of drug delivery.File | Dimensione | Formato | |
---|---|---|---|
prod_334531-doc_166788.pdf
solo utenti autorizzati
Descrizione: Low Cost Synthesis of Smart Biocompatible Graphene Oxide Reduced Species by means of GFP
Tipologia:
Versione Editoriale (PDF)
Dimensione
676.33 kB
Formato
Adobe PDF
|
676.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.